2 results match your criteria: "Lawson Health Research Institute and Nuclear Medicine Department[Affiliation]"
Nucl Med Commun
January 2010
Lawson Health Research Institute and Nuclear Medicine Department, St. Joseph's Health Care, London, Canada.
Purpose: Previous studies have shown the ability of rubidium-82 ((82)Rb) positron emission tomography (PET) imaging to quantitatively measure myocardial blood flow (MBF), many of which are performed using two-dimensional (2D) imaging. Three-dimensional (3D) imaging provides increased sensitivity and may result in decreased costs owing to a reduction in the required injected activity of radiotracer. This study compares 2D and 3D (82)Rb PET MBF results obtained in the same imaging session.
View Article and Find Full Text PDFNucl Med Commun
January 2010
Imaging Program, Lawson Health Research Institute and Nuclear Medicine Department, St. Joseph's Health Care, London, Canada.
Background: Myocardial viability and quantification of regional myocardial blood flow (MBF) are important for the diagnosis of heart disease. Positron emission tomography is the current gold standard for determining myocardial viability, but most positron-emitting perfusion tracers require an on-site cyclotron. Rubidium-82 ((82)Rb) is a myocardial perfusion tracer that is produced using an on-site generator.
View Article and Find Full Text PDF